Leukocyte DNA Methylation Signature Differentiates Pancreatic Cancer Patients from Healthy Controls

Pancreatic adenocarcinoma (PaC) is one of most difficult tumors to treat. Much of this is attributed to the late diagnosis. To identify biomarkers for early detection, we examined DNA methylation differences in leukocyte DNA between PaC cases and controls in a two-phase study. In phase I, we measure...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedersen, Katrina S., Bamlet, William R., Oberg, Ann L., de Andrade, Mariza, Matsumoto, Martha E., Tang, Hui, Thibodeau, Stephen N., Petersen, Gloria M., Wang, Liang
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063802/
https://www.ncbi.nlm.nih.gov/pubmed/21455317
http://dx.doi.org/10.1371/journal.pone.0018223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3063802/
https://www.ncbi.nlm.nih.gov/pubmed/21455317
http://dx.doi.org/10.1371/journal.pone.0018223

Ejemplares similares